ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway.

Wei Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.